HOME >> BIOLOGY >> NEWS
Lutein supplements may improve vision

A substance found in dark green leafy vegetables and egg yolks may improve vision in people with retinitis pigmentosa (RP) and other degenerative eye conditions, according to a study published by a Johns Hopkins researcher, whose subjects were recruited from the Internet and tested via e-mail.

Twelve of the 16 study participants with retinal degenerative conditions reported that taking daily supplements of the substance, called lutein, over a six-month period significantly improved their vision. Lutein is an antioxidant needed by the retina (the light-sensitive layer in the back of the eye) to neutralize the damaging effects of short wavelength light and free radicals. Study results were published in the March issue of Optometry: Journal of the American Optometric Association.

Study participants were recruited after a member of an international retinal degeneration patient e-mail list noted that several of her electronic pen pals said their vision improved after adding lutein supplements to their diets. She then asked Gislin Dagnelie, Ph.D., an assistant professor of ophthalmology at Hopkins' Wilmer Eye Institute, for help in designing vision tests for a study of the supplement.

The subjects took lutein supplements with breakfast every day for six months, 40 mg/day for nine weeks and 20 mg/day thereafter. Half of the participants also took 500 mg/day of DHA (a fatty acid found in fish oil), vitamin B complex and digestive enzymes. Ten of the participants who already were taking vitamin A and/or beta carotene continued to take those supplements. They tested their vision on eye charts sent as e-mail attachments and on wall charts they were instructed to create, and returned data via weekly e-mails to the study coordinators.

Besides the increase in visual acuity and visual field size among most patients, the researchers noticed that blue-eyed participants had substantially higher gains in vision than dark-eyed participants. In addition, tho
'"/>

Contact: Karen Infeld
kinfeld@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
21-May-2000


Page: 1 2

Related biology news :

1. Dietary Lutein Inhibits Mammary Tumor Growth And Normalizes Immune Balance In Tumor-Bearing Mice
2. Dietary Carotenoid Lutein Reduces Atherosclerotic Lesion Formation In Mice
3. Safety of isoflavones in dietary supplements targeted by Illinois initiative
4. Virtual counselor supplements traditional genetic counseling
5. Calcium supplements associated with decreased risk of large bowel polyps
6. Studies show preventive value of food supplements
7. Study says: whey to greater muscle strength is through training and protein supplements
8. Folic acid-iron supplements reduce risk of low birth weight
9. Folic acid supplements not linked to multiple births
10. Nutritional supplements may combat muscle loss
11. Genistein-containing supplements may stop tamoxifen

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Lutein supplements may improve vision

(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
(Date:5/23/2013)... Some prostate cancer patients unnecessarily undergo surgery or ... differences between slow-growing and aggressive forms of the ... Johns Hopkins Medical Institutes are developing technology that ... opt for relatively mild treatments or take drastic ... Anant Madabhushi, an associate professor of biomedical engineering ...
(Date:5/23/2013)... world are billions of animal and plant specimens from ... all stacked, stored and preserved in jars and collection ... critical to understanding how the Earth,s biodiversity is changing ... if only the information were easily accessible. , A ... of a team from the University of Colorado Boulder, ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 2CU-Boulder helps tap crowds to digitize museum records of bugs and plants 3CU-Boulder helps tap crowds to digitize museum records of bugs and plants 4
(Date:5/23/2013)... -- BioScrip, Inc. (NASDAQ: BIOS ) today announced ... Global Healthcare Conference to be held June 3-6, 2013 ... Richard Smith , President and Chief Executive ... Financial Officer, will present on Monday, June 3, 2013 ... About BioScrip BioScrip, Inc. provides comprehensive infusion and ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan Racing ... cord blood stem cell banking and therapeutics, announced today ... No. 16 Acorn Stairlifts Indy car driven by ... remainder of the IZOD IndyCar 2013 season.   ... work to support awareness of umbilical cord blood banking ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... May 23, 2013 The New Jersey ... industries, Black Data Processing Associates (BDPA), is hosting its ... 8, 2013. This all-day event will encourage students and ... the ins and outs from many of the industries’ ... at the New Jersey Institute of Technology, the event ...
Breaking Biology Technology:StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
Cached News: